Related Experiment Video

Updated: Jul 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

A follow-up study of children hospitalised with community-acquired pneumonia

K M Eastham1, D M Hammal, L Parker

  • 1School of Clinical Medical Sciences (Child Health), University of Newcastle upon Tyne, Newcastle upon Tyne, UK.

Archives of Disease in Childhood
|April 3, 2008
PubMed

Insights

Children hospitalized with community-acquired pneumonia (CAP) show long-term respiratory issues, including persistent cough and abnormal chest shape. Parental atopy influences lung function deficits and asthma risk, highlighting the need for targeted follow-up care.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Epidemiology

Background:

  • Community-acquired pneumonia (CAP) is a common childhood illness.
  • Long-term respiratory sequelae after childhood CAP require further investigation.
  • Understanding risk factors for adverse outcomes is crucial for effective patient management.

Purpose of the Study:

  • To assess the long-term respiratory outcomes in children previously hospitalized with radiologically confirmed CAP.
  • To identify factors associated with persistent respiratory symptoms and lung function deficits.
  • To explore the role of parental atopy in determining post-CAP respiratory health.

Main Methods:

  • A controlled follow-up study involving 103 children with a history of CAP and 248 matched controls.
  • Data collected via respiratory questionnaires, clinical examinations, and spirometry.
  • Multiple regression analysis used to identify associations between CAP and respiratory outcomes.

Main Results:

  • Children with a history of CAP were significantly more likely to experience persistent cough and have an abnormal chest shape.
  • Cases with an atopic parent showed reduced lung function (FEV1% and FVC%) but not increased asthma risk.
  • Cases with a non-atopic parent had a higher risk of developing asthma, without significant lung function deficits.

Conclusions:

  • Hospitalization for CAP in childhood is linked to lasting deficits in lung function and persistent respiratory symptoms.
  • Parental atopy appears to be a significant factor influencing the specific respiratory outcomes post-CAP.
  • Current follow-up recommendations for these children are insufficient, necessitating further research and guideline development.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: